Practising Law Institute Developments in Pharmaceutical and Biotech Patent Law 2024

Fish & Richardson Principal Michael Autuoro will present “Proving Infringement in ANDA Cases: Beyond the Label” at the Practising Law Institute’s (PLI) Developments in Pharmaceutical and Biotech Patent Law 2024 on November 22.

Fish is proud to support the PLI, a nonprofit learning organization dedicated to keeping attorneys and other professionals at the forefront of knowledge in their fields. Session details are below.

Proving Infringement in ANDA Cases: Beyond the Label
Friday, November 22 | 9:15-10:15 a.m. ET

This session will discuss how to prove infringement in ANDA cases when patent infringement issues are not indisputably resolved by the label, including how courts address issues such as intent for indirect infringement and infringement under Sunovian. After completing this session, participants will have a greater understanding of:

• Evidence of underlying direct infringement for indirect infringement of method claims
• Intent required for contributory infringement and induced infringement of method claims
• Infringement as a technical act versus under a declaratory judgment action claim: differences in proof and remedies

Speakers:

• Michael Autuoro, Principal, Fish & Richardson
• Jennifer H. Wu, Partner, Groombridge, Wu, Baughman & Stone
• Angus Chen, Ph.D., Partner, Quinn Emanuel Urquhart & Sullivan
• Irene E. Hudson, VP, Legal, North America & Global Regulatory, Aptar
• Chad J. Peterman, Partner, Paul Hastings

For more information, click here.